| Therapeutic Failure | Therapeutic Success | [P] | [IC] | |
| Gender | ||||
| Male | 20 | 382 | 0.01 | [0.24 - 0.83] |
| Female | 23 | 197 | ||
| Father’survival | ||||
| Alive | 20 | 480 | 0.00 | [0.094 - 0.33] |
| Deceased | 23 | 99 | ||
| Mother’survival | ||||
| Alive | 15 | 435 | 0.00 | [0.09 - 0.34] |
| Deceased | 28 | 144 | ||
| Compliance | ||||
| >95% | 20 | 508 | 0.00 | [0.06 - 0.23] |
| | 23 | 71 | ||
| WHO Stage | ||||
| Stage 1 et 2 | 23 | 357 | 0.000015 | [0.16 - 0.58] |
| Stage 3 et 4 | 20 | 95 | ||
| CD4 Count | ||||
| >200 | 3 | 37 | 0.135 | [0.09 - 1.43] |
| | 9 | 40 | ||
| Plasma C V | ||||
| <1000 | 3 | 397 | 0.00 | [0.010 - 0.05] |
| >ou = 1000 | 40 | 182 |